{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-083237","form_type":"8-K","ticker":"DRIO","cik":"0001533998","company_name":"DarioHealth Corp.","filed_at":"2023-07-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.226252+00:00","generated_at":"2026-06-13T04:12:12.165513+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"DarioHealth reports preliminary Q2 revenue $6.0-6.15M, new health plan contract for 160K hypertension members","bullets":["Preliminary Q2 2023 revenue $6.0-6.15M, driven by B2B channel growth for 10th consecutive quarter.","Preliminary six-month revenue $13-13.15M; cash and equivalents $52.6M as of June 30, 2023.","New agreement with large regional health plan to provide hypertension digital solution to over 160,000 members, launching July 2023.","Strategic partnerships with MedOne (attributed to Sanofi) and Plan (attributed to Solera) expected to contribute to 2023 revenue.","Private-labeled Aetna platform delivered on schedule; member enrollment expected in 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-083237","json":"https://secwatch.observer/filing/0001104659-23-083237.json","markdown":"https://secwatch.observer/filing/0001104659-23-083237.md","text":"https://secwatch.observer/filing/0001104659-23-083237.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533998/000110465923083237/0001104659-23-083237-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533998/000110465923083237/tm2321687d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T04:12:12.165513+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"248aa56907cecd7fa983d1bc387f2007f9f7dc3b","claim":"DarioHealth Corp. reported second quarter ended June 30, 2023 results: revenue between $6.0 million and $6.15 million.","evidence_excerpt":"Dario also announced today preliminary unaudited revenue results for the three months ended June 30, 2023 of between $6.0 million and $6.15 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465923083237/0001104659-23-083237-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended June 30, 2023"},{"label":"Revenue","value":"between $6.0 million and $6.15 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}